A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...

From condemning the Jan. 6 Capitol riots to helping fund the President-elect’s impending inauguration, recent years have seen ...

Recognizing the increased use of artificial intelligence in the development of new therapies, the U.S. FDA on Monday released ...

An unnamed 19-year-old in Canada's breasts ballooned from a B cup to triple G cup six months after receiving her first dose ...

We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at ...

Scientists discover that SARS-CoV-2 spike protein remains in the brain and skull bone marrow for years post-infection, ...

Pfizer Healthcare India and GITAM University launch PAT programme to empower rural girls in pharmaceutical and healthcare sectors.

Novo Nordisk filed another petition with the FDA seeking to block compounding pharmacies from making versions of one of its GLP-1 drugs ...

The startup is developing a kind of macrocyles, which share strengths of both small molecules and biologics, to make oral ...

A patient-led study examines the potential of extended Paxlovid courses for Long COVID relief, documenting varied outcomes ...

By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.

Long-standing partnership as strong foundation for extended collaboration Expanded cooperation in global RISE with SAP transformation projects ...